These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8563891)
21. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis. Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925 [TBL] [Abstract][Full Text] [Related]
22. Polarized production of T-helper cell type 1 cells in Peyer's patches in Crohn's disease. Kudo T; Nagata S; Aoyagi Y; Suzuki R; Matsuda H; Ohtsuka Y; Shimizu T; Okumura K; Yamashiro Y Digestion; 2004; 70(4):214-25. PubMed ID: 15627769 [TBL] [Abstract][Full Text] [Related]
23. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease. Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891 [TBL] [Abstract][Full Text] [Related]
24. Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease. Agnholt J; Kaltoft K Cytokine; 2001 Aug; 15(4):212-22. PubMed ID: 11563881 [TBL] [Abstract][Full Text] [Related]
25. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210 [TBL] [Abstract][Full Text] [Related]
26. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820 [TBL] [Abstract][Full Text] [Related]
27. Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease. Maerten P; Geboes K; De Hertogh G; Shen C; Cadot P; Bullens DM; Van Assche G; Penninckx F; Rutgeerts P; Ceuppens JL Clin Immunol; 2004 Sep; 112(3):239-46. PubMed ID: 15308117 [TBL] [Abstract][Full Text] [Related]
28. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Griga T; Voigt E; Gretzer B; Brasch F; May B Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639 [TBL] [Abstract][Full Text] [Related]
29. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients. Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184 [TBL] [Abstract][Full Text] [Related]
30. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Di Sabatino A; Ciccocioppo R; Cupelli F; Cinque B; Millimaggi D; Clarkson MM; Paulli M; Cifone MG; Corazza GR Gut; 2006 Apr; 55(4):469-77. PubMed ID: 16105889 [TBL] [Abstract][Full Text] [Related]
31. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease. Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649 [TBL] [Abstract][Full Text] [Related]
32. Expression of costimulatory molecules B7-1 and B7-2 in macrophages and granulomas of Crohn's disease: demonstration of cell-to-cell contact with T lymphocytes. Hara J; Ohtani H; Matsumoto T; Nakamura S; Kitano A; Arakawa T; Nagura H; Kobayashi K Lab Invest; 1997 Aug; 77(2):175-84. PubMed ID: 9274860 [TBL] [Abstract][Full Text] [Related]
37. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation. Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017 [TBL] [Abstract][Full Text] [Related]
38. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. Kruidenier L; Kuiper I; Lamers CB; Verspaget HW J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014 [TBL] [Abstract][Full Text] [Related]
39. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866 [TBL] [Abstract][Full Text] [Related]
40. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. Murata Y; Ishiguro Y; Itoh J; Munakata A; Yoshida Y J Gastroenterol; 1995 Nov; 30 Suppl 8():56-60. PubMed ID: 8563892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]